According to Research by SNS Insider, the U.S. Peptide Therapeutics Market is Set to Reach USD 35.71 Billion by 2032, Supported by Rising Adoption of Precision Biologics and Advances in Peptide ...

Scientists comment on a UK Health Security Agency (UKHSA) announcement that a new mpox strain has been identified in England. Dr Jonas Albarnaz, Institute Fellow, Capripoxvirus Biology, Pirbright ...

The vaccine developers market shows significant opportunities through increased demand, collaborative partnerships, and ...

Newton Biocapital enters as new investor, strong participation of existing investors; Pivotal Phase 2b trial initiation in 2027 of BIOX-101 to treat intracerebral hemorrhage ; BIO ...

Competitive Landscape, Recent Expansions, Partnerships and Collaborations, Big Pharma Initiatives and Cost Price Analysis" report has been added to ResearchAndMarkets.com's offering. The ...

This is just one strand, however. UK researchers are working extensively to help understand the large-DNA virus that causes ...

Arpita Bose and Zhecheng Zhang explore genetic tools in environmental microbes, citing applications in extracellular electron transfer ...

Susan Ringdal EVP, Strategic Planning and Global Affairs +44 (0)20 7399 2760/ +44 7776 477050 Steven Weiss US Communications +1 732 788 8279 ...

Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...

Dyadic International, Inc. ( DYAI) IAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 December 9, 2025 9:30 AM EST Good day, and welcome to the iAcessAlpha Virtual Best Ideas winter ...

This article examines some of the cell-based approaches that researchers are using to study acquired drug resistance and the effects of specific genetic variants on cancer cell physiology.

This important study reveals that mitotic release of an ER-microtubule tether is critical for normal mitotic progression. Manipulating CLIMP63 phosphorylation, the authors provide convincing evidence ...